These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6130751)

  • 21. Agoraphobia: a review for the physician.
    Vale WH; Mlott SR
    South Med J; 1980 Dec; 73(12):1607-10. PubMed ID: 6108614
    [No Abstract]   [Full Text] [Related]  

  • 22. Cognitive change during treatment of agoraphobia. Behavioral and cognitive-behavioral approaches.
    Last CG; Barlow DH; O'Brien GT
    Behav Modif; 1984 Apr; 8(2):181-210. PubMed ID: 6148064
    [No Abstract]   [Full Text] [Related]  

  • 23. Brief behavior therapy with an elderly patient. a case study.
    Garfinkel R
    J Geriatr Psychiatry; 1979; 12(1):101-9. PubMed ID: 45443
    [No Abstract]   [Full Text] [Related]  

  • 24. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalization of therapeutic changes in agoraphobia: the role of perceived self-efficacy.
    Williams SL; Kinney PJ; Falbo J
    J Consult Clin Psychol; 1989 Jun; 57(3):436-42. PubMed ID: 2567745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massed vs. spaced exposure sessions in the treatment of agoraphobia.
    Foa EB; Jameson JS; Turner RM; Payne LL
    Behav Res Ther; 1980; 18(4):333-8. PubMed ID: 6108104
    [No Abstract]   [Full Text] [Related]  

  • 27. One-session treatment of specific phobias: a detailed description and review of treatment efficacy.
    Zlomke K; Davis TE
    Behav Ther; 2008 Sep; 39(3):207-23. PubMed ID: 18721635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative efficacy of imaginal and in vivo desensitization in the treatment of agoraphobia.
    James JE; Hampton BA; Larsen SA
    J Behav Ther Exp Psychiatry; 1983 Sep; 14(3):203-7. PubMed ID: 6139389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural and drug treatments of phobic and obsessive-compulsive disorders.
    Marks I
    Psychother Psychosom; 1986; 46(1-2):35-44. PubMed ID: 2885893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of agoraphobia with group exposure in vivo and imipramine.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1980 Jan; 37(1):63-72. PubMed ID: 6101535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agoraphobia: newer treatment approaches.
    Rohs RG; Noyes R
    J Nerv Ment Dis; 1978 Oct; 166(10):701-8. PubMed ID: 702127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behaviour therapy in phobic and obsessional disorders.
    Cobb J
    Psychiatr Dev; 1983; 1(4):351-65. PubMed ID: 6144099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
    Mavissakalian M
    Psychopharmacol Bull; 1989; 25(1):27-9. PubMed ID: 2672069
    [No Abstract]   [Full Text] [Related]  

  • 35. Agoraphobia: the 'what if' syndrome.
    Fier M
    J Med Soc N J; 1981 Apr; 78(4):286-8. PubMed ID: 6939897
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of self-exposure instructions on agoraphobic outpatients.
    Behav Res Ther; 1979; 17(1):83-5. PubMed ID: 36069
    [No Abstract]   [Full Text] [Related]  

  • 37. Suitability for insight-oriented psychotherapy as a prognostic factor in treatment of phobic women.
    Persson G; Alström JE
    Acta Psychiatr Scand; 1984 Apr; 69(4):318-26. PubMed ID: 6144246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive modification versus prolonged exposure in vivo: a comparison with agoraphobics as subjects.
    Emmelkamp PM; Kuipers AC; Eggeraat JB
    Behav Res Ther; 1978; 16(1):33-41. PubMed ID: 27165
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of mobile phones in the behavioral treatment of driving phobias.
    Flynn TM; Taylor P; Pollard CA
    J Behav Ther Exp Psychiatry; 1992 Dec; 23(4):299-302. PubMed ID: 1363820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy for agoraphobia.
    Scott WB; Fleming BM; Kritkausky RP
    Arch Gen Psychiatry; 1988 Apr; 45(4):387-8. PubMed ID: 2895622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.